UNSPSC 51123702: Tedisamil

This classification denotes an antiarrhythmic agent with the molecular formula C19H32N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) A5VAY2U3R8, chemically known as 3,7-bis(cyclopropylmethyl)spiro(cyclopentane-1,9-(3,7)diazabicyclo(3.3.1)nonane) but more generally known as tedisamil, which bears US NIH Compound Identifier 65825. European Medicines Agency schedules Tedisamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10864MIG.

UNSPSC 51123702 Tedisamil is a Commodity code that encompasses emergency and advanced life support medications supplied to municipal fire and rescue services. State and local governments use this code to procure injectable medications such as epinephrine, adenosine, labetalol, and diltiazem—drugs administered by paramedics and advanced life support personnel in acute medical emergencies. Municipal fire departments and rescue services are the primary buying organization under this code, with solicitations typically structured as competitive sealed bids for firm fixed-price supply contracts with pharmaceutical vendors. Vendors must meet strict pharmaceutical compliance requirements including OSHA Safety Data Sheet documentation, minimum shelf-life guarantees (typically nine months or longer from acceptance), warranty provisions against defects, and expedited delivery windows (often ten calendar days or less). Small local business enterprise set-asides and accessibility compliance (WCAG 2.2 Level AA and Section 508 standards) appear in recent solicitations.

The City of Tampa's Purchasing Department posted a representative recent opportunity in April 2026 (Solicitation 26P00188, due April 8, 2026) for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida. The IFB solicited 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with an estimated contract value of $40,000.00. The solicitation included a 5 percent bid discount for SLBE participation (not to exceed $10,000), one-year initial term with two optional one-year renewals plus up to three 30-day unilateral extensions, and award to the lowest responsive, responsible bidder within 120 days of bid opening. The source shows limited recent activity—a single posted opportunity in Florida—with no additional geographic or issuing-body data to characterize broader state and local procurement patterns under this code.